Press releases
- Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
- Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
- Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 47.78 |
---|---|
High | 48.11 |
Low | 47.74 |
Bid | 45.82 |
Offer | 47.64 |
Previous close | 47.56 |
Average volume | 484.10 |
---|---|
Shares outstanding | 58.23m |
Free float | 57.21m |
P/E (TTM) | -- |
Market cap | 2.74bn USD |
EPS (TTM) | -3.35 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 14:29 BST.
More ▼